2016
DOI: 10.1242/jcs.186163
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of cargo export at ER exit sites and the trans-Golgi network by the secretion inhibitor FLI-06

Abstract: Export out of the endoplasmic reticulum (ER) involves the Sar1 and COPII machinery acting at ER exit sites (ERES). Whether and how cargo proteins are recruited upstream of Sar1 and COPII is unclear. Two models are conceivable, a recruitment model where cargo is actively transported through a transport factor and handed over to the Sar1 and COPII machinery in ERES, and a capture model, where cargo freely diffuses into ERES where it is captured by the Sar1 and COPII machinery. Using the novel secretion inhibitor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
27
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 18 publications
(31 citation statements)
references
References 62 publications
(80 reference statements)
3
27
0
Order By: Relevance
“…GCA insensitivity indicates that the NS1 and CAV-1 interaction initiates in the ER compartment. In agreement, treatment of mosquito cells with Fli-06 showed no effect on NS1 secretion, indicating that the interaction between NS1 and CCC takes place very early after NS1 synthesis, before the viral protein is transported to the ERES (22,23).…”
Section: Discussionsupporting
confidence: 56%
“…GCA insensitivity indicates that the NS1 and CAV-1 interaction initiates in the ER compartment. In agreement, treatment of mosquito cells with Fli-06 showed no effect on NS1 secretion, indicating that the interaction between NS1 and CCC takes place very early after NS1 synthesis, before the viral protein is transported to the ERES (22,23).…”
Section: Discussionsupporting
confidence: 56%
“…Upon shifting to the permissive temperature (32 °C), VSVG-EYFP folds properly, exits the ER and travels to the plasma membrane [36, 37]. Using its N-glycosylation sites the localization can be assessed with the help of endoglycosidaseH (endoH), because ER-localized VSVG-EYFP is endoH-sensitive whereas Golgi and beyond-localized VSVG-EYFP is endoH resistant [31]. In HeLa cells transfected with ATL3 or ATL3 Y192C together with VSVG-EYFP only the Y192C mutation, but not the wild type, slowed down ER–Golgi transport (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…There is some scope here for further development and some early work in this area has already identified potential inhibitors of COPII-dependent budding (Yonemura et al 2016). The essential nature of the COPII pathway means that specific inhibitors are unlikely to be of therapeutic benefit; however, there might be further scope in targeting cargo-specific interactions, the interplay between protein folding and export, or the efficiency of the process itself.…”
Section: Future Perspectivesmentioning
confidence: 99%